Skip to content
My WebMD Sign In, Sign Up

Parkinson's Disease Health Center

Font Size

Drug Shows Promise in Treating Parkinson's Psychosis

Pimavanserin may have fewer side effects than current therapy, study suggests

continued...

In addition to psychosis relief, the researchers reported other benefits of the drug. Patients taking pimavanserin slept better and the improvement in mental functioning also helped caregivers, who found it easier to care of their patients, Ballard said.

Motor symptoms of the people taking the drug didn't get worse, the study found.

Dr. Susan Fox, an associate professor of neurology at the University of Toronto, wrote an accompanying journal editorial about the new findings.

"Treating psychosis in Parkinson's disease is challenging because of side effects of current drugs -- especially potentially worsening Parkinson's disease motor symptoms. Pimavanserin offers an alternative without this risk," Fox said.

Pimavanserin was well tolerated and side effects were mild to moderate, and similar in the two groups. The most common side effects were urinary tract infections (12 percent for placebo versus 13 percent for pimavanserin) and falls (9 percent for placebo versus 11 percent for pimavanserin), the researchers found.

However, 10 patients stopped taking pimavanserin because of a side effect, compared with two patients in the placebo group, the authors noted.

According to Ballard, the U.S. Food and Drug Administration has invited a new drug application based on this trial, "so the decision regarding approval should probably be in 12 to 18 months," he said.

1|2

Today on WebMD

Parkinsons disease illustration
Slideshow
Parkinsons Disease Symptoms
Article
 
Preventing Falls
Article
caregiver
Article
 
Parkinsons Disease Medications
Article
Questions Doctor Parkinsons
Article
 
Eating Right
Article
Parkinsons Exercise
Article
 
daughter consoling depressed mother
Article
senior man's hands
Article
 
Parkinsons Daily
Article
Acupunture
Article